中国1990—2021年5岁以下儿童结核病疾病负担变化趋势

陶璐秋; 章紫钰; 谭高; 邹言峥; 潘丽; 朱宏儒; 钱熠礼; 刘小利; 汪伟

doi:10.16835/j.cnki.1000-9817.2024358

中国1990—2021年5岁以下儿童结核病疾病负担变化趋势

doi: 10.16835/j.cnki.1000-9817.2024358

陶璐秋¹,
章紫钰²,
谭高³,
邹言峥¹,
潘丽¹,
朱宏儒¹,
钱熠礼¹,
刘小利^3, ,,
汪伟^1, ,

1.
国家卫生健康委员会寄生虫病预防与控制技术重点实验室/江苏省寄生虫与媒介控制技术重点实验室/江苏省血吸虫病防治研究所，无锡 214064
2.
南京医科大学康达学院
3.
中国人民武装警察部队湖南省总队医院

基金项目: 军队临床培育专科项目

详细信息

作者简介:
陶璐秋(1997-)，女，江苏南京人，硕士，研究实习员，主要研究方向为传染病流行病学

章紫钰(2005-)，女，江苏无锡人，在读本科

通讯作者:
刘小利，E-mail：liuxiaoli515@126.com

汪伟，E-mail：wangwei@jipd.com

利益冲突声明 所有作者声明无利益冲突。
陶璐秋与章紫钰为共同第一作者。
中图分类号: R179 R181.3⁺² R529.9
计量
- 文章访问数: 177
- HTML全文浏览量: 65
- PDF下载量: 25
- 被引次数: 0
出版历程
- 收稿日期: 2024-10-31
- 修回日期: 2024-11-21
- 刊出日期: 2024-12-25

Temporal trend of tuberculosis burden among children under 5 years old in China from 1990 to 2021

TAO Luqiu¹,
ZHANG Ziyu²,
TAN Gao³,
ZOU Yanzheng¹,
PAN Li¹,
ZHU Hongru¹,
QIAN Yili¹,
LIU Xiaoli^{3
, ,},
WANG Wei^{1
, ,}

1.
National Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi (214064), Jiangsu Province, China

摘要

摘要: 目的分析1990—2021年中国5岁以下儿童结核病疾病负担变化趋势，为制定中国儿童结核病防控措施提供科学依据。方法基于2021年全球疾病负担数据集(GBD 2021)，收集1990—2021年中国和全球5岁以下儿童结核病发病率、患病率、死亡率和伤残调整生命年(disability-adjusted life year, DALY)等数据。比较不同性别儿童和不同类型结核病发病率、患病率、死亡率和DALY率，采用Joinpoint回归模型计算1990—2021年中国和全球儿童结核病疾病负担变化的年度百分比(APC)和平均年度百分比(AAPC)，分析其变化趋势。结果 2021年中国5岁以下儿童结核病新发病例数、患病数和死亡数分别为0.97万，847.78万和0.02万例，所致DALY为2.71万人年。1990—2021年中国和全球5岁以下儿童结核病发病率、患病率、死亡率、DALY率均呈下降趋势(AAPC值分别为-5.45%，-1.14%，-12.37%，-11.34%；-2.38%, -1.41%, -4.66%, -4.56%, P值均 < 0.05)；中国5岁以下儿童结核病发病率、死亡率、DALY率下降均快于全球总体水平(P < 0.05)。1992年及以后，男童结核病新发病例数、患病数、死亡病例数和所致DALY均高于女童。1990—2021年药物敏感结核病发病率、患病率、死亡率、DALY率均呈下降趋势，耐多药结核病发病率和患病率在2015年后有所上升。结论 1990—2021年中国5岁以下儿童结核病疾病负担下降明显，但近年来耐多药结核病疾病负担有所上升。需高度重视儿童结核病防控工作，进一步完善耐药结核病的诊断和治疗。
- 结核 /
- 患病代价 /
- 回归分析 /
- 伤残调整生命率 /
- 儿童，学龄前
Abstract: Objective To analyze the trends in disease burden of tuberculosis among children under 5 years of age in China from 1990 to 2021, so as to provide insights for future tuberculosis control measures among children in China. Methods Based on the Global Burden of Disease (GBD) 2021 datasets, the incidence, prevalence, mortality and disability-adjusted life year(DALY) of tuberculosis of children under 5 years of age in China and globally were collected from 1990 to 2021. The incidence, prevalence, mortality and DALY rate of tuberculosis were compared by genders and types. In addition, the annual percent change(APC) and the average annual percent change(AAPC) of children's tuberculosis burden in China and globally from 1990 to 2021 were calculated by using the Joinpoint regression model, and the changing trends were analyzed. Results The numbers of incident, prevalent and dead tuberculosis cases were 9 700, 8 477 800 and 200 among children under 5 years of age in China in 2021, and the DALY due to tuberculosis were 27 100 person-years. There were significant reductions in incidence, prevalence, mortality and DALY rate of tuberculosis among children under 5 years of age in China (AAPC=-5.45%, -1.14%, -12.37%, -11.34%) and globally(AAPC=-2.38%, -1.41%, -4.66%, -4.56%), and the reductions in the incidence, mortality and DALY rate were more significant in China than globally (P < 0.05).In 1992 and later, the numbers of incident, prevalent and dead tuberculosis cases and the DALY of tuberculosis were higher among male than among female. In addition, the disease burden of drug-susceptible tuberculosis appeared a tendency of downward in China from 1990 to 2021, while the incidence and prevalence of extensively drug-resistant tuberculosis rose since 2015. Conclusions The disease burden of tuberculosis remarkably reduced among children under 5 years of age in China from 1990 to 2021. However, the burden of disease due to multidrug-resistant tuberculosis appeared an upward trend recently. Increased attention is required to be paid to the prevention and control of tuberculosis among children and improved diagnosis and treatment of drug-resistant tuberculosis are recommended.
- Tuberculosis /
- Cost of illness /
- Regression analysis /
- Disability-adjusted life year /
- Child, preschool
注释:

1) 利益冲突声明 所有作者声明无利益冲突。

2) 陶璐秋与章紫钰为共同第一作者。

HTML全文

图 1 中国和全球1990—2021年5岁以下儿童TB疾病负担指标Joinpoint回归分析

Figure 1. Joinpoint regression analysis of the trends in the disease burden of TB among children under 5 years of age in China and globally, 1990-2021

下载: 全尺寸图片幻灯片

图 2 中国1990—2021年不同性别5岁以下儿童TB疾病负担变化趋势

Figure 2. Trends in burden of TB among children under 5 years of age by gender in China from 1990 to 2021

下载: 全尺寸图片幻灯片

图 3 中国1990—2021年5岁以下儿童不同类型TB疾病负担变化趋势

Figure 3. Trends in disease burden of different TB types in children under 5 years of age in China from 1990 to 2021

下载: 全尺寸图片幻灯片

表 1 中国1990和2021年中国5岁以下儿童不同性别TB疾病负担情况

Table 1. Disease burden of TB among children under 5 years of age in China by gender in 1990 and 2021

性别	发病数/万		患病数/万		死亡数/万		DALY数/万人年
性别	1990年	2021年	1990年	2021年	1990年	2021年	1990年	2021年
男	4.05(3.07~5.19)	0.49(0.39~0.62)	938.88(750.46~1 133.17)	458.06(373.61~560.35)	0.87(0.66~1.12)	0.01(0.01~0.02)	79.71(61.48~102.66)	1.58(1.25~2.01)
女	3.81(2.86~4.93)	0.48(0.37~0.60)	792.85(625.08~968.01)	389.72(316.02~483.95)	0.89(0.73~1.07)	0.01(0.01~0.01)	81.40(66.77~97.68)	1.13(0.87~1.38)
注： ()内数据为95%UI。

下载: 导出CSV

参考文献(19)

[1]	中华人民共和国国家卫生健康委关于印发健康儿童行动提升计划(2021—2025年)的通知[EB/OL]. (2021-11-05)[2024-10-29]. http://www.nhc.gov.cn/fys/s3585/202111/554a64ff0eff4971a37db413a00083a6.shtml. Notice of the National Health Commission of the PRC on the issuance of the Action Promotion Plan for Healthy Children (2021-2025)[EB/OL]. (2021-11-05)[2024-10-29]. http://www.nhc.gov.cn/fys/s3585/202111/554a64ff0eff4971a37db413a00083a6.shtml. (in Chinese)
[2]	中华医学会结核病学分会儿童结核病专业委员会, 中国研究型医院学会结核病学专业委员会, 国家呼吸系统疾病临床医学研究中心, 等. 儿童肺结核诊断专家共识[J]. 中华实用儿科临床杂志, 2022, 37(7): 490-496. doi: 10.3760/cma.j.cn101070-20211207-01436 Pediatric Tuberculosis Speciality Committees of Society of Tuberculosis, Chinese Medical Association, Tuberculosis Speciality Committees of Chinese Research Hospital Association, National Clinical Research Center for Respiratory Diseases, et al. Expert consensus on the diagnosis of pulmonary tuberculosis in children[J]. Chin J Appl Clin Pediatr, 2022, 37(7): 490-496. (in Chinese) doi: 10.3760/cma.j.cn101070-20211207-01436
[3]	GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet, 2024, 403(10440): 2133-2161. doi: 10.1016/S0140-6736(24)00757-8
[4]	GBD 2021 Tuberculosis Collaborators. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO end TB strategy: a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet Infect Dis, 2024, 24(7): 698-725. doi: 10.1016/S1473-3099(24)00007-0
[5]	KIM H J, FAY M P, FEUER E J, et al. Permutation tests for joinpoint regression with applications to cancer rates[J]. Stat Med, 2000, 19(3): 335-51. doi: 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z
[6]	World Health Organization. Global tuberculosis report 2023[M]. Geneva: WHO, 2023.
[7]	LAUZARDO M, NODURFT-FROMAN M. Eliminating tuberculosis: the importance of paediatric tuberculosis surveillance[J]. Lancet Public Health, 2019, 4(10): e485-e486. doi: 10.1016/S2468-2667(19)30148-3
[8]	MARAIS B J, AMANULLAH F, GUPTA A, et al. Tuberculosis in children, adolescents, and women[J]. Lancet Respir Med, 2020, 8(4): 335-337. doi: 10.1016/S2213-2600(20)30077-1
[9]	戴萌娜, 袭燕, 尹文强, 等. 1990—2019年中国结核病疾病负担现状及趋势分析[J]. 中国慢性病预防与控制, 2022, 30(10): 792-797. DAI M N, XI Y, YIN W Q, et al. Current status and trends of disease burden of tuberculosis in China from 1990 to 2019[J]. Chin J Prev Control Chronic Dis, 2022, 30(10): 792-797. (in Chinese)
[10]	AKALU T Y, CLEMENTS A C A, WOLDE H F, et al. Economic burden of multidrug-resistant tuberculosis on patients and households: a global systematic review and Meta-analysis[J]. Sci Rep, 2023, 13(1): 22361. doi: 10.1038/s41598-023-47094-9
[11]	HU Y, MATHEMA B, ZHAO Q, et al. Acquisition of second-line drug resistance and extensive drug resistance during recent transmission of mycobacterium tuberculosis in rural China[J]. Clin Microbiol Infect, 2015, 21(12): 1093. e9-1093. e18. doi: 10.1016/j.cmi.2015.08.023
[12]	LI Y, LI Y, WANG T, et al. Multidrug-resistant mycobacterium tuberculosis transmission in Shandong, China[J]. Medicine (Baltimore), 2024, 103(12): e37617. doi: 10.1097/MD.0000000000037617
[13]	JIANG Q, LIU Q, JI L, et al. Citywide transmission of multidrug-resistant tuberculosis under China's rapid urbanization: a retrospective population-based genomic spatial epidemiological study[J]. Clin Infect Dis, 2020, 71(1): 142-151. doi: 10.1093/cid/ciz790
[14]	DUAN Q, ZHANG Z, TIAN D, et al. Transmission of multidrug-resistant mycobacterium tuberculosis in Wuhan, China: a retrospective molecular epidemiological study[J]. Medicine (Baltimore), 2022, 101(4): e28751. doi: 10.1097/MD.0000000000028751
[15]	中华医学会结核病学分会儿童结核病专业委员会, 国家儿童医学中心, 首都医科大学附属北京儿童医院, 等. 儿童结核分枝杆菌潜伏感染筛查和预防性治疗专家共识[J]. 中华结核和呼吸杂志, 2020, 43(4): 345-349. doi: 10.3760/cma.j.cn112147-20200106-00006 Pediatric Tuberculosis Speciality Committees of Society of Tuberculosis, Chinese Medical Association, National Center for Children's Health, Beijing Children's Hospital, Capital Medical University, et al. Expert concesus on screening and prophylactic treatment of mycobacterium tuberculosis latent infections among children[J]. Chin J Tuberc Respir Dis, 2020, 43(4): 345-349. (in Chinese) doi: 10.3760/cma.j.cn112147-20200106-00006
[16]	ZELNER J L, MURRAY M B, BECERRA M C, et al. Age-specific risks of tuberculosis infection from household and community exposures and opportunities for interventions in a high-burden setting[J]. Am J Epidemiol, 2014, 180(8): 853-861. doi: 10.1093/aje/kwu192
[17]	王晓君, 李月华, 易凤莲, 等. 1990－2017年中国结核病流行与控制情况[J]. 中华流行病学杂志, 2020, 41(6): 856-860. doi: 10.3760/cma.j.cn112338-20190809-00587 WANG X J, LI Y H, YI F L, et al. Description of epidemic features and control status on tuberculosis in China, 1990-2017[J]. Clin J Epidemiol, 2020, 41(6): 856-860. (in Chinese) doi: 10.3760/cma.j.cn112338-20190809-00587
[18]	ZHANG S X, MIAO F Y, YANG J, et al. Global, regional, and national burden of HIV-negative tuberculosis, 1990-2021: findings from the global burden of disease study 2021[J]. Infect Dis Poverty, 2024, 13(1): 60. doi: 10.1186/s40249-024-01227-y
[19]	HOFFMANN J, HORSBURGH C R Jr. Addressing gaps in the diagnosis of TB in children[J]. IJTLD Open, 2024, 1(10): 429-430. doi: 10.5588/ijtldopen.24.0239